GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » 3-Year FCF Growth Rate

Sisram Medical (HKSE:01696) 3-Year FCF Growth Rate : 26.90% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical 3-Year FCF Growth Rate?

Sisram Medical's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.51.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 26.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 10 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Sisram Medical was 26.90% per year. The lowest was -9.80% per year. And the median was 0.60% per year.


Competitive Comparison of Sisram Medical's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Sisram Medical's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sisram Medical's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Sisram Medical's 3-Year FCF Growth Rate falls into.



Sisram Medical 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Sisram Medical  (HKSE:01696) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Sisram Medical 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Sisram Medical's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sisram Medical (HKSE:01696) Business Description

Traded in Other Exchanges
N/A
Address
HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Sisram Medical (HKSE:01696) Headlines

No Headlines